ResMed Inc (RMD)

Quick ratio

Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Cash US$ in thousands 932,711 521,944 426,361 238,361 237,910 210,247 209,100 227,891 227,894 253,199 207,163 273,710 201,769 194,476 276,149 295,278 230,635 255,865 421,414 463,156
Short-term investments US$ in thousands 12,026 21,537 7,617 11,821 12,423 12,115 4,980 9,167 17,842 19,566 33,138 24,011 2,020
Receivables US$ in thousands 907,825 859,937 811,198 837,275 817,190 729,740 692,388 704,909 686,264 672,271 620,483 575,950 508,580 550,719 601,353 614,292 525,014 518,817 474,478 484,095
Total current liabilities US$ in thousands 940,516 851,960 904,079 910,655 773,030 764,073 770,802 758,533 761,691 732,714 692,659 689,299 667,265 621,064 624,158 911,766 876,541 577,335 590,853 602,761
Quick ratio 1.96 1.62 1.37 1.19 1.39 1.24 1.18 1.25 1.22 1.27 1.19 1.25 1.09 1.23 1.46 1.00 0.89 1.34 1.52 1.57

March 31, 2025 calculation

Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($932,711K + $—K + $907,825K) ÷ $940,516K
= 1.96

The quick ratio of ResMed Inc. demonstrates notable fluctuations over the analyzed period, indicating shifts in the company's short-term liquidity position. Starting from a relatively strong value of 1.57 as of June 30, 2020, the ratio experienced a gradual decline through December 31, 2020, reaching 1.34. This downward trend continued more markedly by March 31, 2021, with the ratio dropping to 0.89, reflecting a significant decrease in liquid assets relative to current liabilities.

Subsequently, the ratio recovered somewhat, rising back to 1.00 in June 2021 and further improving to 1.46 by September 2021, suggesting an enhancement in liquidity. The value slightly declined again to 1.23 at the end of 2021 and maintained a moderate level around 1.09 to 1.25 through June 2022 to September 2022. The ratio remained relatively stable during this period, indicating ongoing liquidity management.

Starting from the end of 2022, the ratio exhibited modest increases and decreases, generally staying above 1.2, with values like 1.27 at December 2022 and 1.22 in March 2023. A slight decrease occurred by June 2023 to 1.25, followed by a minor dip to 1.18 in September 2023. Notably, the ratio climbed again to 1.24 at the end of 2023 and showed upward momentum into early 2024, reaching 1.39 in March 2024, but then dipped to 1.19 by June 2024 before rising significantly to 1.37 in September 2024 and subsequently increasing to 1.62 at December 2024.

The most recent data point, as of March 31, 2025, indicates a further increase to 1.96, approaching nearly double the initial levels observed in 2020. This progression suggests a consistent strengthening of ResMed Inc.'s liquid asset position relative to its current liabilities in recent periods.

Overall, the trend of the quick ratio highlights periods of both liquidity strain and recovery, with recent data illustrating a marked improvement in the company's short-term liquidity profile, which may indicate enhanced financial resilience or improved management of quick assets relative to current liabilities.